MIT CEO


June 17-18, 2025

Koch Institute at MIT


You are invited to join MIT CEO, June 17-18 at the Koch Institute. Co-hosted with MIT President Sally Kornbluth, Nobelist Phil Sharp (co-founder Biogen/Alnylam), Bob Langer (co-founder Moderna/Momenta), MIT CEO brings together leaders in the industry for off-the-record discussions in the heart of Cambridge’s Kendall Square.



Reserve your spot now

Featured Speakers

Policy and Provider Perspectives

John Crowley

CEO

BIO


Maura Healey

Governor

Massachusetts



Peter Hutt

General Counsel (former)

FDA

Anne Klibanski

President & CEO

Mass General Brigham

Peter Marks

Director, CBER

FDA



Academic Leaders

George Daley

Dean

Harvard Medical School

Sally Kornbluth

President

MIT



Bob Langer

NAS

Professor

MIT

Craig Mello

Nobelist

UMass Medical School

Phil Sharp

Nobelist

Professor

MIT

BioPharma CEOs

Harvey Berger

CEO

Kojin Therapeutics



Yvonne Greenstreet

CEO

Alnylam

Ken Keller

CEO

Daiichi Sankyo, Inc.



Nello Mainolfi

CEO

Kymera



Christophe Weber

CEO

Takeda

Pharma R&D & Strategy Leaders

Eliav Barr

CMO

Merck



Nouhad Husseini

SVP, Head, BD & Corporate Strategy

Regeneron

Julie Kim

President, US

Takeda



Soren Moller

Managing Partner

Novo Holdings



Deniz Razon

CBO

Servier



Discussion Panels

  • (Big Bio)Pharma Pipeline Sourcing
  • Translating Science into Medicine
  • Driving Productivity in R&D
  • Regulatory & Industry Roundtable
  • Targeted Licensing & Acquisitions
  • Platform to Pipeline
  • Developing an Effective Board
  • Navigating Partnerships Across Border
  • Managing the Runway
  • Ecosystem of External Innovation
  • Supporting Research at the Intersection of Policy & Science
  • Capital Markets Perspectives
  • Innovative Commercial Models
  • Navigating the Regulatory Landscape
  • Maintaining Patient-Centric Focus
  • Assessing Investment Risk
  • Identifying Next-Generation Rx 
  • Innovation in Clinical Trials
  • Accelerating Drug Development
  • Ensuring Health Equity & Access
  • R&D Collaboration
  • Advancing Late-Stage Assets

As part of the Longwood Healthcare Leaders series, Longwood hosts semiannual invitation-only industry meetings with thought leaders and decision-makers across government, pharma, biotech, to discuss areas of collaboration and access to innovation in order to accelerate the translation of discoveries into medicines to help patients. Additional details are online here: www.longwoodhealthcareleaders.com/mitceo

Supporters 

To learn more about getting involved, contact sg@longwoodfund.com

LHCL Logo Transparent.png

#LongwoodHealthcareLeaders

Upcoming Events:

Miami CEO: April 9 -11, 2025

MIT CEO: June 17-18, 2025

Boston CEO: October 27-28, 2025

San Francisco CEO: January 10-11, 2026

LinkedIn  X
  翻译: